News

10 out of the first cohort of 30 Women of Impact named by UArizona Research, Innovation and Impact are inventors actively working to bring their work to the world through commercial pathways.

University of Arizona researchers have developed a new class of drugs that is able to cross the blood-brain barrier and could be used to treat degenerative neurological diseases and conditions. The university has licensed these new drug designs to startup Teleport Pharmaceuticals.

On June 14 and 15, 2022, the National Academy of Inventors gathered for its 11th annual meeting at the Sheraton Wild Horse Pass in Phoenix, Arizona. The event included ceremonies honoring the newest class of NAI Senior Members and Fellows, which included five UArizona inventors.

On May 25, 2022, we gathered with friends and colleagues to celebrate the opening of our new offices at The Refinery at the UA Tech Park at The Bridges. Check out the photo recap!

Between FY2017 and FY2021, TLA activities generated a $1.61 billion economic output and supported thousands of jobs. A new report on the economic impacts generated by the UArizona commercialization office outlines these findings and projects continued growth over the next 10 years.

Professor Jeffrey Pyun and Assistant Professor Thomas Gianetti have been recognized with new UArizona faculty awards for innovation and entrepreneurship; both demonstrated significant involvement in expanding the impact of their research to the public good through a focus on commercialization.

Around the world, countries are on the cyber-offense. UArizona researchers have invented new strategies to mitigate these attacks by helping make cybersecurity for the “internet of things” (IoT) more accessible. Based on the technology, they have launched a startup, BG Networks, to bring the invention to the public.

An optical sciences Ph.D. student has developed a new way for precisely measuring radio antenna surfaces. TLA worked with him to patent the technology and now he has launched a startup, Fringe Metrology. 

The UArizona has been selected as one of over 50 world-class institutions participating in the Novartis Global Scholars Program (NGSP). The Novartis Institutes for BioMedical Research NGSP is a competitive program designed for innovators from invited institutions to gain $1M over 3-years in funding for breakthrough science not covered by traditional grant support.